Drug Profile
Niacin/lovastatin
Alternative Names: Advicor; KS 01022; Nicostatin; Nicotinic acid/lovastatinLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Kos Pharmaceuticals
- Developer AbbVie
- Class Antihyperlipidaemics; Naphthalenes; Nicotinic acids; Vitamins
- Mechanism of Action Cholesterol inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Hyperlipidaemia
Most Recent Events
- 17 Aug 2011 Sepracor Pharmaceuticals is now called Sunovion Pharmaceuticals Canada
- 03 Jun 2008 Oryx Pharmaceuticals has been acquired by Sepracor
- 13 Dec 2006 Kos Pharmaceuticals has been acquired by Abbott Laboratories